Detection of minimal residual disease in leukaemia.
作者信息
Katz F E
出版信息
Arch Dis Child. 1992 Jun;67(6):671-3. doi: 10.1136/adc.67.6.671.
Abstract
摘要
相似文献
1
Detection of minimal residual disease in leukaemia.
Arch Dis Child. 1992 Jun;67(6):671-3. doi: 10.1136/adc.67.6.671.
2
Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis.
Br J Haematol. 1999 Apr;105(1):7-24.
3
[Immunophenotyping in acute leukemia: detection of minimal residual disease].
Orv Hetil. 2000 Nov 12;141(46):2487-92.
4
[Minimal residual disease in childhood acute leukemias].
Przegl Lek. 2006;63(1):41-3.
5
Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
Best Pract Res Clin Haematol. 2002 Mar;15(1):91-103. doi: 10.1053/beha.2002.0187.
6
CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
Leukemia. 2005 Jul;19(7):1281-4. doi: 10.1038/sj.leu.2403769.
7
Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis.
Chin Med J (Engl). 1997 Jan;110(1):73-7.
8
Minimal residual disease diagnostics in acute lymphoblastic leukaemia: impact of primer characteristics and size of junctional regions.
Br J Haematol. 2014 Feb;164(3):451-3. doi: 10.1111/bjh.12621. Epub 2013 Oct 26.
9
Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry.
Leuk Lymphoma. 1994;13 Suppl 1:87-90. doi: 10.3109/10428199409052682.
10
Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.
Best Pract Res Clin Haematol. 2002 Mar;15(1):37-57. doi: 10.1053/beha.2002.0184.
本文引用的文献
1
2
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies.
J Natl Cancer Inst. 1980 Jul;65(1):33-42.
3
Asynchronous antigen expression in B lineage acute lymphoblastic leukemia.
Blood. 1988 Jul;72(1):299-307.
4
Rearrangement of T-cell delta locus in lymphoproliferative disorders.
Blood. 1988 Jul;72(1):353-7.
5
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5698-702. doi: 10.1073/pnas.85.15.5698.
6
Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification.
Science. 1987 Jul 10;237(4811):175-8. doi: 10.1126/science.3110950.
7
The molecular genetics of Philadelphia chromosome-positive leukemias.
N Engl J Med. 1988 Oct 13;319(15):990-8. doi: 10.1056/NEJM198810133191506.
8
T cell receptor gamma chain variable gene rearrangements in acute lymphoblastic leukemias of T and B lineage.
Eur J Immunol. 1987 Nov;17(11):1593-7. doi: 10.1002/eji.1830171111.
9
Usage of gamma chain variable regions in human acute lymphoblastic leukemias.
Blood. 1988 Dec;72(6):2038-41.
10
The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemia.
Br J Haematol. 1989 Oct;73(2):173-80. doi: 10.1111/j.1365-2141.1989.tb00249.x.
Zotero 插件